RJA
FMI

Raymond James & Associates’s Foundation Medicine, Inc. FMI Stock Holding History

Raymond James & Associates’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,448
Closed -$272K – 3713
2018
Q1 		$272K Sell
3,448
-130
-4% -$9.59K ﹤0.01% 2945
2017
Q4 		$244K Buy
+3,578
New +$186K ﹤0.01% 2946

Other funds holding FMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Raymond James & Associates's FMI Position: Q2 2018 in Review

Raymond James & Associates sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 3,448 shares — an estimated $272K sold.

Raymond James & Associates first reported a position in FMI in Q4 2017 and held it in 2 quarters. The position peaked at $272K in Q1 2018. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.

  • Raymond James & Associates reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
  • Raymond James & Associates sold 3,448 Foundation Medicine, Inc. shares in Q2 2018, an estimated $272K.
  • Raymond James & Associates first reported a position in Foundation Medicine, Inc. in Q4 2017 and held it in 2 quarters.
  • Raymond James & Associates's Foundation Medicine, Inc. position peaked at $272K in Q1 2018.
  • 157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.

Based on Raymond James & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.